Conan MedTech
Conan MedTech has pioneered a rapid Point-of-Care diagnostic device, utilizing a highly specific salivary biomarker to diagnose potential concussions in athletes and soldiers.
About Conan MedTech
We aim to become the first in-market, saliva-based concussion detector to reshape the future of concussion care.
Recent Funding lists Conan MedTech under Health and bio (also Education). It went through IndieBio (IndieBio NY 04).
Funding rounds
- IndieBio NY 04
IIndieBio · batchSource: indiebio.co - Website created
- X account created
Investors
Similar Health and bio companies
HHexagon Bio$62M Series B+ · Oct 2026
BBioStack$9.5M Seed · Oct 2026HHeyVoli$500K Pre Seed · Oct 2026
VVitalls$1.5M Seed · Oct 2026
WWarp Sciences$215M Series A · Oct 2026
PPAM2L Biotechnologies$29.97M Series A · Oct 2026
Questions and sources
Conan MedTech: questions and answers
- Who invested in Conan MedTech?
- Investors on record for Conan MedTech: IndieBio.
Every amount links to the page it came from. * Estimated from an accelerator's published standard deal, not a company-specific disclosure. How Recent Funding sources and verifies funding data. The same data as JSON: /api/v1/companies/conan-medtech (get a free API key).